Dear Editor, Neuromyelitis optica spectrum disorder (NMOSD) presents with characteristic patterns of hemispheric white-matter lesions in magnetic resonance imaging (MRI), including tumefactive lesions, long spindle-like or radial-shape lesions following white-matter tracts, and asymmetric extensive and confluent hemispheric lesions.
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4+; normal range, 1+ to 4+). She met the 2015 revised diagnostic criteria for NMOSD by having one core clinical characteristic (optic neuritis) and positivity in a test for anti-AQP4 antibody. Anti-Sjögren' s syndrome-related antigen A and antiSjögren' s syndrome-related antigen B antibodies were also detected. Further tests including Schirmer's test (bilaterally positive, 3 mm/2.5 mm) and salivary gland scintigraphy (decreased tracer uptake in parotid and submandibular glands) suggested the presence of Sjögren's syndrome. She was treated with intravenous methylprednisolone for 5 days at 1 g daily, and was then started on prednisolone to prevent further attacks. Her left visual acuity gradually improved, and there was no recurrence during her 10-month follow-up in our clinic.
The detection of anti-AQP4 antibody makes it possible to understand some MRI lesions considered typical of NMOSD. However, most of the reported MRI features of NMOSD are based on relatively short-term changes, and little is known about MRI changes in patients with long-standing NMOSD.
Our patient had anti-AQP4-positive NMOSD satisfying the 2015 revised diagnostic criteria for NMOSD. However, the less-well-known MRI changes in NMOSD resembling leukodystrophy were unexpected. In this case there was no convincing evidence for the coexistence of inherited leukodystrophies, mitochondrial disorders, and metabolic or toxic encephalopathy. On the other hand, we cannot exclude the possibility of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) because we did not conduct the applicable genetic testing. However, the lack of a family history, the absence of clinical features suggestive of CADASIL (e.g., strokes, migraines, and dementia), and some unusual MRI findings for CADASIL (abnormalities in the deep cerebellar white matter) reduce the likelihood of CADASIL. 5 Our patient had Sjögren' s syndrome, which may affect the occurrence of leukodystrophy-like whitematter lesions. Three cases of NMOSD with a leukodystrophylike MRI pattern have been reported recently. [2] [3] [4] One of these cases had Sjögren's syndrome, like our patient, 3 but not the other two. 2, 4 In addition, although some studies have found cerebral white-matter lesions in Sjögren's syndrome, 6 ,7 leukodystrophy-like white-matter changes have not been reported previously. Given that two of the three reported NMOSD cases were not associated with Sjögren' s syndrome and leukodystrophy-like white-matter lesions in Sjögren' s syndrome alone were not previously reported, the brain lesions of our patient were more likely to be related to current NMOSD than Sjögren's syndrome. However, the coexistence of Sjögren's syndrome may have enhanced the probability of leukodystrophic changes.
As indicated in Table 1 , our case and the previous three NMOSD cases with a leukodystrophy-like MRI pattern were, overall, anti-AQP4-positive, long-standing NMOSD (disease duration ≥9 years), and mainly presented with either optic 2-4 An especially notable point is that all of them initially showed normal or only subtle brain MRI changes, indicating that leukodystrophy-like white-matter lesions are a feature of long-standing disease. In addition, NMOSD cases with Sjögren's syndrome-constituting two out of the four cases including the current case-showed a low relapse rate compared to those without Sjögren's syndrome.
The present case has indicated that a patient with anti-AQP4-positive long-standing NMOSD can exhibit MRI features similar to those of leukodystrophy. Therefore, this littleknown leukodystrophy-like MRI pattern should be considered as one brain imaging feature of long-standing NMOSD.
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